Global Endowment Management’s Gilead Sciences GILD Stock Holding History

Global Endowment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-26,100	Closed	-$1.76M	–	121
2019 Q2	$1.76M	Sell	26,100 -37,900	-59%	-$2.49M	0.17%	52
2019 Q1	$4.16M	Buy	+64,000	New	+$4.25M	0.59%	30
2018 Q4	–	Sell	-87,200	Closed	-$6.73M	–	191
2018 Q3	$6.73M	Buy	+87,200	New	+$6.59M	0.89%	22
2018 Q1	–	Sell	-48,200	Closed	-$3.45M	–	226
2017 Q4	$3.45M	Buy	+48,200	New	+$3.66M	0.5%	43
2017 Q3	–	Sell	-50,340	Closed	-$3.56M	–	250
2017 Q2	$3.56M	Buy	50,340 +5,000	+11%	+$333K	0.49%	28
2017 Q1	$3.08M	Buy	45,340 +5,700	+14%	+$401K	0.45%	39
2016 Q4	$2.84M	Sell	39,640 -6,300	-14%	-$468K	0.44%	37
2016 Q3	$3.63M	Buy	+45,940	New	+$3.73M	0.6%	34

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Global Endowment Management's GILD Position: Q3 2019 in Review

Global Endowment Management sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 26,100 shares — an estimated $1.76M sold.

Global Endowment Management first reported a position in GILD in Q3 2016 and held it in 8 quarters. The position peaked at $6.73M in Q3 2018. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

Global Endowment Management reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
Global Endowment Management sold 26,100 Gilead Sciences shares in Q3 2019, an estimated $1.76M.
Global Endowment Management first reported a position in Gilead Sciences in Q3 2016 and held it in 8 quarters.
Global Endowment Management's Gilead Sciences position peaked at $6.73M in Q3 2018.
1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Global Endowment Management's 13F filing for Q3 2019, filed 13 Nov 2019.